ISRCTN17717066终止未知
A prospective ‘real-world data’ registry and sample collection study for patients with diffuse large B-cell lymphoma
Clatterbridge Cancer Centre NHS Foundation Trust0 个研究点目标入组 0 人开始时间: 2021年8月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Males and female subjects =16 years of age at the time of enrolment
- •2. Ability to understand and sign written informed consent
- •3. Histologically proven diffuse large B cell non-Hodgkin’s lymphoma (DLBCL) according to current World Health Organisation 2016 guidelines that fall into one of two cohorts that will be independently evaluated/reported:
- •3.1. DLBCL patients with de novo disease unfit for full dose R-CHOP
- •3.2. DLBCL patients with relapsed/refractory disease
- •4. Patients fulfilling the above criteria who are on other trials/studies are eligible for recruitment
排除标准
- •Patients commencing index treatments >6 months prior to trial enrolment (Cohorts A or B). In other words, patients can be retrospectively entered (for Cohorts A or B). This exclusion does not apply to prior therapies before the index treatment event for Cohort B.
研究者
相似试验
尚未招募
不适用
ARORA: Advanced Hormone Receptor Positive Breast Cancer Registry in AustraliaBreast cancer HR positive, HER2 negative breast cancerHR positive, HER2 negative breast cancerCancer - BreastAdvanced Breast CancerBreast cancerACTRN12621000216819The Walter and Eliza Hall Institute of Medical research (WEHI)300
Unknown
不适用
Real world data collection and population-based analysis of incidence of patients with acute myeloid leukemia (AML).Goal: to determine overall survival of AML patients in the province of Friesland (NL) and to determine whether overall survival is dependent on the factors mentioned. Early death will also be determined.NL-OMON22811Stichting HemoBase200
已完成
不适用
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in males <= 17 years of age undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy.bronze Schilder disease10029299AdrenoleukodystrophyNL-OMON47132bluebird bio6
尚未招募
4 期
A prospective, multicenter, large sample registry-based study of Angong Niuhuang Pills for StrokeStrokeITMCTR2100005305Integrated Hospital of Traditional Chinese Medicine, Southern Medical University
招募中
不适用
Data collection of the patients receiving Grafalon® (Observational i.e. Non interventional)CTRI/2018/02/012258Cadila Healthcare Ltd